EXINI Diagnostics AB
About EXINI Diagnostics AB
EXINI Diagnostics AB, established in 1999, is a healthcare AI company specializing in automated analysis of diagnostic images. The company commercializes AI methods developed by a research group at Lund University, focusing on certified medical device software. EXINI has developed automated analysis platforms for cardiac, brain, bone, and PSMA (Prostate-Specific Membrane Antigen) scans.
Their flagship product, the automated Bone Scan Index (aBSI), is widely adopted in approximately 1,000 hospitals globally for quantifying bone tumor burden in patients with metastatic prostate cancer. Additionally, products like aPROMISE and PYLARIFY AI leverage artificial intelligence and deep learning to provide quantitative assessment of PSMA PET/CT in oncology. These tools aim to enhance consistency, efficiency, accuracy, and reproducibility in image assessments, supporting physicians in standardized reporting, treatment selection, and monitoring of treatment response for prostate cancer patients.
EXINI Diagnostics AB operates as a wholly owned subsidiary of Lantheus Holdings, Inc., an established leader in innovative imaging diagnostics, targeted therapeutics, and artificial intelligence solutions for serious medical conditions. The company’s software provides diagnostic and clinical decision support by interpreting medical digital images and offering diagnostic suggestions, thereby assisting physicians in their diagnostic process across various conditions including cancer, coronary artery disease, dementia, and Parkinson’s disease.
Focus Areas
Business Intelligence
| Key Investors | Augmenta (Sweden), Ideon Science Park Incubator, LU Innovation (Lund), Mobile Heights Business Center, Ideon Innovation |
| Partnerships | Siemens Healthineers, Curium, INmune Bio, Bayer AG, Veterans Affairs Greater Los Angeles Healthcare System, FUJIFILM Toyama Chemical Co., Prostate Cancer Clinical Trials Consortium (PCCTC), GE Healthcare |
| Acquisitions | Acquired by Progenics Pharmaceuticals Inc. in 2015; Progenics Pharmaceuticals Inc. acquired by Lantheus Holdings, Inc. in 2020 |
| Technology | AI methods for automated analysis of diagnostic images, deep learning algorithms, artificial neural networks, web-based systems, cloud infrastructure |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
For physicians, EXINI Diagnostics AB's solutions offer several key advantages. Their AI-powered platforms, such as aPROMISE for PSMA PET/CT and aBSI for bone scans, provide objective, quantitative, and reproducible assessments of disease burden, which can significantly enhance diagnostic accuracy and consistency across reads. This automation reduces the laborious task of manual interpretation, leading to improved efficiency and faster reporting times. The standardized reports generated by their software facilitate better communication within multidisciplinary teams and adherence to clinical guidelines like the PROMISE criteria. Furthermore, the ability to perform longitudinal analysis of scans allows for precise monitoring of disease progression and treatment response, supporting more informed decision-making in patient management and personalized treatment strategies. Their products are backed by evidence-based research and hold necessary regulatory clearances (CE Mark, FDA 510(k)), ensuring reliability and clinical utility.
EXINI Diagnostics AB's AI-enabled software is designed for seamless integration into existing clinical workflows. Their platforms, including aPROMISE and aBSI, can be deployed as secure web cloud applications or local server applications and are capable of integrating with institution image acquisition platforms, Picture Archiving and Communication Systems (PACS), and leading clinical workstations from partners like Siemens Healthineers, GE Healthcare, and Bayer AG. This ensures that the quantitative reports, available in DICOM and PDF formats, can be easily incorporated into a physician's review process.
What the Web Says
EXINI Diagnostics AB develops AI-powered software for medical image analysis, particularly in nuclear medicine and oncology. Their products, such as aPROMISE and EXINI bone, assist healthcare professionals in quantifying disease and analyzing medical images. The company has recently focused on integrating its AI solutions with major healthcare platforms and collaborating with pharmaceutical companies.
Overall: MixedStrengths
- AI-powered quantitative analysis for medical images.
- Reduces errors and speeds up clinical workflows.
- Provides objective and standardized reporting.
- Integrated with major imaging platforms like Siemens Healthineers' syngo.via.
- Potential to expand clinical utility of PSMA PET in prostate cancer management.
- Good for entry-level lab experience (general diagnostics industry, not specific to EXINI).
Limitations
- Semiautomatic methods require careful review to avoid errors.
- Software may underestimate bone scan index in extended bone metastases.
- Potential for misclassification (e.g., kidney uptake as metastasis).
- Limited public reviews directly for EXINI Diagnostics AB as an employer or product on major platforms like G2, Glassdoor, Capterra, or Reddit.
- General diagnostic industry concerns include low pay, poor management, and limited advancement opportunities.
- Some diagnostic companies experience high turnover and toxic work environments.
Based on reviews from: RevMed, Exini Diagnostics AB Newsroom, MDPI, G2, Indeed.com, Capterra
Last updated: 2026-07-18
Videos
News, demos, and interviews about EXINI Diagnostics AB.
Videos load interactively. If none appear, search YouTube for EXINI Diagnostics AB →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]